Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, marking the second biologic approved as an add-on maintenance treatment ...

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD) ...

Sue’s recommendation to others living with COPD is to not isolate yourself and stay at home. It is okay to ask for help and ...

GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD if it gets approved by the FDA.

News News: The Directorate of Higher Secondary Education (DHSE), Kerala has released the 2025 Plus Two re-evaluation results on its official website, dhsekerala.

Ambry Genetics, now a wholly owned subsidiary of Tempus AI - a tech company advancing precision medicine through the practical application of AI in healthcare and a leader in clinical genomic testing, ...